Compare VRDN & LXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRDN | LXP |
|---|---|---|
| Founded | 2006 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.0B |
| IPO Year | N/A | 1993 |
| Metric | VRDN | LXP |
|---|---|---|
| Price | $32.11 | $49.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | $41.17 | ★ $54.17 |
| AVG Volume (30 Days) | ★ 1.2M | 498.0K |
| Earning Date | 02-26-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 5.58% |
| EPS Growth | N/A | ★ 487.65 |
| EPS | N/A | ★ 1.90 |
| Revenue | $70,789,000.00 | ★ $364,335,000.00 |
| Revenue This Year | $26,257.62 | N/A |
| Revenue Next Year | $4.54 | $1.97 |
| P/E Ratio | ★ N/A | $26.42 |
| Revenue Growth | ★ 23340.07 | 6.98 |
| 52 Week Low | $9.90 | $34.25 |
| 52 Week High | $34.29 | $52.52 |
| Indicator | VRDN | LXP |
|---|---|---|
| Relative Strength Index (RSI) | 52.45 | 55.15 |
| Support Level | $29.63 | $49.32 |
| Resistance Level | $34.29 | $51.30 |
| Average True Range (ATR) | 1.35 | 0.97 |
| MACD | 0.00 | -0.51 |
| Stochastic Oscillator | 59.29 | 21.81 |
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.